Neuralink on Friday announced that it has received US FDA approval to begin its first-in-human clinical study, which means that actual humans could have a Neuralink device implanted in their heads
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study,” Neuralink tweeted
“This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people,” it added
On receiving the FDA approval, Musk also tweeted congratulating the Neuralink team
Moreover, the company said that the recruitment for the clinical trial is not open yet, and it will announce more information regarding this soon
In March, the FDA rejected Neuralink‘s bid to implant a chip in a human brain over safety risks
In December last year, Musk had claimed Neuralink’s device is ready for human trials and he is expecting to do so in about six months after experimenting it on pigs and monkeys
However, Musk’s Neuralink would not be the first to implant a brain-computer interface into humans